China is fast becoming a major player in the global pharmaceutical and biotech industries. Once focused primarily on generic and me-too drugs, Chinese companies are now making headlines with innovative breakthroughs in oncology and gene therapy. Foreign investors are taking notice, pouring billions into partnerships and research projects across the country. ... Show More
Jun 13
Tokenmaxxing and the Corporate AI Pullback
AI tools were expected to help companies work faster, spend less money, and become more productive. But what happens when employees use so much AI that costs become too high? In this episode, Skip Montreux and Dez Morgan look at tokenmaxxing — a new business problem where AI cost ... Show More
25m 16s
Nov 2024
Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
<p>What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ... Show More
53m 58s
Sep 2024
How Chinese Industry Got Too Good Too Fast
For decades, China was the go-to for low-cost manufacturing, but now it's a global leader in advanced industries. How did China leapfrog the competition, and what does this mean for the global economy? We explore the rapid rise of Chinese industry and its implications for the fut ... Show More
14m 45s